Two Sigma Investments, LP Lava Therapeutics Nv Transaction History
Two Sigma Investments, LP
- $40.3 Billion
- Q1 2024
A detailed history of Two Sigma Investments, LP transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Two Sigma Investments, LP holds 82,031 shares of LVTX stock, worth $147,655. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82,031Holding current value
$147,655% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LVTX
# of Institutions
26Shares Held
3.76MCall Options Held
28KPut Options Held
43.4K-
Redmile Group, LLC San Francisco, CA2.07MShares$3.73 Million0.27% of portfolio
-
Bruce & Co., Inc. Chicago, IL772KShares$1.39 Million1.27% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3368KShares$661,6470.19% of portfolio
-
Walleye Capital LLC Plymouth, MN155KShares$278,3980.0% of portfolio
-
Alpha Wave Global, LP New York, NY108KShares$194,2300.2% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $46.4M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...